Maternal obesity is associated with chorioamnionitis and earlier indicated preterm delivery among expectantly managed women with preterm premature rupture of membranes

Emily E. Hadley, Andrea Discacciati, Maged Costantine, Mary Munn, Luis Pacheco, George Saade, Giuseppe Chiossi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: To determine the association between maternal obesity and delivery due to chorioamnionitis prior to labor onset, among expectantly managed women with preterm premature rupture of membranes (pPROM). Methods: This was a secondary analysis of a multicenter randomized trial of magnesium sulfate versus placebo to prevent cerebral palsy or death among offspring of women with anticipated delivery at 24–31-week gestation. After univariable analysis, Cox proportional hazard evaluated the association between maternal obesity and chorioamnionitis, while Laplace regression investigated how obesity affects the gestational age at delivery of the first 20% of women developing the outcome of interest. Results: A total of 164 of the 1942 women with pPROM developed chorioamnionitis prior to labor onset. Obese women had a 60% increased hazard of developing such complication (adjusted HR 1.6, 95%CI 1.1–2.1, p = .008), prompting delivery 1.5 weeks earlier, as the 20th survival percentile was 27.2-week gestation (95%CI 26–28.6) among obese as opposed to 28.8 weeks (95%CI 27.4–30.1) (p = .002) among nonobese women. Conclusions: Maternal obesity is a risk factor for chorioamnionitis prior to labor onset. Future studies will determine if obesity is important enough to change the management of latency after pPROM according to maternal BMI.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalJournal of Maternal-Fetal and Neonatal Medicine
DOIs
StateAccepted/In press - Sep 22 2017

Fingerprint

Chorioamnionitis
Obesity
Mothers
Labor Onset
Pregnancy
Magnesium Sulfate
Cerebral Palsy
Gestational Age
Multicenter Studies
Preterm Premature Rupture of the Membranes
Placebos
Survival

Keywords

  • chorioamnionitis
  • indicated preterm delivery
  • Obesity
  • pregnancy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Maternal obesity is associated with chorioamnionitis and earlier indicated preterm delivery among expectantly managed women with preterm premature rupture of membranes. / Hadley, Emily E.; Discacciati, Andrea; Costantine, Maged; Munn, Mary; Pacheco, Luis; Saade, George; Chiossi, Giuseppe.

In: Journal of Maternal-Fetal and Neonatal Medicine, 22.09.2017, p. 1-8.

Research output: Contribution to journalArticle

@article{722c7fc2bafa4a3c860c0174944c510d,
title = "Maternal obesity is associated with chorioamnionitis and earlier indicated preterm delivery among expectantly managed women with preterm premature rupture of membranes",
abstract = "Objective: To determine the association between maternal obesity and delivery due to chorioamnionitis prior to labor onset, among expectantly managed women with preterm premature rupture of membranes (pPROM). Methods: This was a secondary analysis of a multicenter randomized trial of magnesium sulfate versus placebo to prevent cerebral palsy or death among offspring of women with anticipated delivery at 24–31-week gestation. After univariable analysis, Cox proportional hazard evaluated the association between maternal obesity and chorioamnionitis, while Laplace regression investigated how obesity affects the gestational age at delivery of the first 20{\%} of women developing the outcome of interest. Results: A total of 164 of the 1942 women with pPROM developed chorioamnionitis prior to labor onset. Obese women had a 60{\%} increased hazard of developing such complication (adjusted HR 1.6, 95{\%}CI 1.1–2.1, p = .008), prompting delivery 1.5 weeks earlier, as the 20th survival percentile was 27.2-week gestation (95{\%}CI 26–28.6) among obese as opposed to 28.8 weeks (95{\%}CI 27.4–30.1) (p = .002) among nonobese women. Conclusions: Maternal obesity is a risk factor for chorioamnionitis prior to labor onset. Future studies will determine if obesity is important enough to change the management of latency after pPROM according to maternal BMI.",
keywords = "chorioamnionitis, indicated preterm delivery, Obesity, pregnancy",
author = "Hadley, {Emily E.} and Andrea Discacciati and Maged Costantine and Mary Munn and Luis Pacheco and George Saade and Giuseppe Chiossi",
year = "2017",
month = "9",
day = "22",
doi = "10.1080/14767058.2017.1378329",
language = "English (US)",
pages = "1--8",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Maternal obesity is associated with chorioamnionitis and earlier indicated preterm delivery among expectantly managed women with preterm premature rupture of membranes

AU - Hadley, Emily E.

AU - Discacciati, Andrea

AU - Costantine, Maged

AU - Munn, Mary

AU - Pacheco, Luis

AU - Saade, George

AU - Chiossi, Giuseppe

PY - 2017/9/22

Y1 - 2017/9/22

N2 - Objective: To determine the association between maternal obesity and delivery due to chorioamnionitis prior to labor onset, among expectantly managed women with preterm premature rupture of membranes (pPROM). Methods: This was a secondary analysis of a multicenter randomized trial of magnesium sulfate versus placebo to prevent cerebral palsy or death among offspring of women with anticipated delivery at 24–31-week gestation. After univariable analysis, Cox proportional hazard evaluated the association between maternal obesity and chorioamnionitis, while Laplace regression investigated how obesity affects the gestational age at delivery of the first 20% of women developing the outcome of interest. Results: A total of 164 of the 1942 women with pPROM developed chorioamnionitis prior to labor onset. Obese women had a 60% increased hazard of developing such complication (adjusted HR 1.6, 95%CI 1.1–2.1, p = .008), prompting delivery 1.5 weeks earlier, as the 20th survival percentile was 27.2-week gestation (95%CI 26–28.6) among obese as opposed to 28.8 weeks (95%CI 27.4–30.1) (p = .002) among nonobese women. Conclusions: Maternal obesity is a risk factor for chorioamnionitis prior to labor onset. Future studies will determine if obesity is important enough to change the management of latency after pPROM according to maternal BMI.

AB - Objective: To determine the association between maternal obesity and delivery due to chorioamnionitis prior to labor onset, among expectantly managed women with preterm premature rupture of membranes (pPROM). Methods: This was a secondary analysis of a multicenter randomized trial of magnesium sulfate versus placebo to prevent cerebral palsy or death among offspring of women with anticipated delivery at 24–31-week gestation. After univariable analysis, Cox proportional hazard evaluated the association between maternal obesity and chorioamnionitis, while Laplace regression investigated how obesity affects the gestational age at delivery of the first 20% of women developing the outcome of interest. Results: A total of 164 of the 1942 women with pPROM developed chorioamnionitis prior to labor onset. Obese women had a 60% increased hazard of developing such complication (adjusted HR 1.6, 95%CI 1.1–2.1, p = .008), prompting delivery 1.5 weeks earlier, as the 20th survival percentile was 27.2-week gestation (95%CI 26–28.6) among obese as opposed to 28.8 weeks (95%CI 27.4–30.1) (p = .002) among nonobese women. Conclusions: Maternal obesity is a risk factor for chorioamnionitis prior to labor onset. Future studies will determine if obesity is important enough to change the management of latency after pPROM according to maternal BMI.

KW - chorioamnionitis

KW - indicated preterm delivery

KW - Obesity

KW - pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85029895306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029895306&partnerID=8YFLogxK

U2 - 10.1080/14767058.2017.1378329

DO - 10.1080/14767058.2017.1378329

M3 - Article

SP - 1

EP - 8

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

ER -